These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33344710)

  • 1. Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice.
    Holanda VAD; Oliveira MC; Da Silva Junior ED; Calo' G; Ruzza C; Gavioli EC
    Neurobiol Stress; 2020 Nov; 13():100255. PubMed ID: 33344710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC; Calo' G
    Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling.
    Holanda VAD; de Almeida RN; de Oliveira MC; da Silva Junior ED; Galvão-Coelho NL; Calo' G; Ruzza C; Gavioli EC
    Psychopharmacology (Berl); 2024 May; 241(5):1001-1010. PubMed ID: 38270614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the NOP receptor signaling affects resilience to acute stress.
    Holanda VAD; Pacifico S; Azevedo Neto J; Finetti L; Lobão-Soares B; Calo G; Gavioli EC; Ruzza C
    J Psychopharmacol; 2019 Dec; 33(12):1540-1549. PubMed ID: 31337258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test.
    Gavioli EC; Marzola G; Guerrini R; Bertorelli R; Zucchini S; De Lima TC; Rae GA; Salvadori S; Regoli D; Calo G
    Eur J Neurosci; 2003 May; 17(9):1987-90. PubMed ID: 12752799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous nociceptin / orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation.
    Leggett JD; Dawe KL; Jessop DS; Fulford AJ
    J Neuroendocrinol; 2009 Nov; 21(11):888-97. PubMed ID: 19732291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.
    Gavioli EC; Vaughan CW; Marzola G; Guerrini R; Mitchell VA; Zucchini S; De Lima TC; Rae GA; Salvadori S; Regoli D; Calo' G
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):547-53. PubMed ID: 15197534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine.
    Holanda VAD; Santos WB; Asth L; Guerrini R; Calo' G; Ruzza C; Gavioli EC
    Psychopharmacology (Berl); 2018 Nov; 235(11):3093-3102. PubMed ID: 30145654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies.
    Rizzi A; Gavioli EC; Marzola G; Spagnolo B; Zucchini S; Ciccocioppo R; Trapella C; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):968-74. PubMed ID: 17329551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus.
    D'Oliveira da Silva F; Azevedo Neto J; Sturaro C; Guarino A; Robert C; Gavioli EC; Calo G; Mouledous L; Ruzza C
    Neuropharmacology; 2022 Jul; 212():109077. PubMed ID: 35513173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice.
    Medeiros IU; Ruzza C; Asth L; Guerrini R; Romão PR; Gavioli EC; Calo G
    Peptides; 2015 Oct; 72():95-103. PubMed ID: 26028163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress.
    Gavioli EC; Holanda VAD; Calo G; Ruzza C
    Peptides; 2021 Jul; 141():170548. PubMed ID: 33862163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect.
    Ciccocioppo R; Cippitelli A; Economidou D; Fedeli A; Massi M
    Physiol Behav; 2004 Aug; 82(1):63-8. PubMed ID: 15234592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.
    Silva AI; Holanda VAD; Azevedo Neto JG; Silva Junior ED; Soares-Rachetti VP; Calo G; Ruzza C; Gavioli EC
    Psychopharmacology (Berl); 2020 Jun; 237(6):1633-1642. PubMed ID: 32095915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Nociceptin/Orphanin FQ Peptide Receptor-Mediated Pain and Anxiety Symptoms in a Preclinical Model of Post-traumatic Stress Disorder.
    Zhang Y; Schalo I; Durand C; Standifer KM
    Front Psychiatry; 2018; 9():731. PubMed ID: 30670988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists.
    Park JY; Chae S; Kim CS; Kim YJ; Yi HJ; Han E; Joo Y; Hong S; Yun JW; Kim H; Shin KH
    Korean J Physiol Pharmacol; 2019 Nov; 23(6):427-448. PubMed ID: 31680765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nociceptin/Orphanin FQ peptide receptor antagonist, SB-612111, improves cerebral blood flow in a rat model of traumatic brain injury.
    Al Yacoub ON; Tarantini S; Zhang Y; Csiszar A; Standifer KM
    Front Pharmacol; 2023; 14():1272969. PubMed ID: 37920208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
    Leggett JD; Jessop DS; Fulford AJ
    Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders.
    Asth L; Tiago PRF; Costa LRF; Holanda VAD; Pacifico S; Zaveri NT; Calo' G; Ruzza C; Gavioli EC
    Neuropeptides; 2020 Aug; 82():102059. PubMed ID: 32600667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands.
    Viaro R; Calcagno M; Marti M; Borrelli E; Morari M
    Neuropharmacology; 2013 Sep; 72():126-38. PubMed ID: 23643745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.